The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
The company is making its entry into the Hyderabad market through its unique asset-light business model
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Funds raised will be used to develop technology and foster healthcare partnerships
Transformation to pure-play Innovative Medicines company nears completion
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Proceeds from the proposed issue will be utilized to part finance Balaxi’s planned EU GMP-compliant manufacturing facility for Oral Solid Dosages and Liquid Injectables at TSIIC Pharma Formulations SEZ
The funding round also saw participation from some of India's top angel investors and leading industry giants
Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Subscribe To Our Newsletter & Stay Updated
